Pharmaceuticals Hong Kong

Hong Kong Bacteriophage Therapy Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Hong Kong Bacteriophage Therapy Market Industry Trends and Forecast to 2034: Segmented by (Type, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Hong Kong · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $0.1 Mn Placeholder estimate
Estimate 2025 $0.1 Mn 0.2% of the global market
Projected 2034 $0.5 Mn 274.4% Adds $0.4 Mn over 9 forecast years
CAGR 2025–2034 15.8% Faster than 74% of 180 Pharmaceuticals markets here
Key players 5 Companies profiled
  • Hong Kong is 0.17% of the global market.
  • In APAC, the largest is China at $6.5 Mn.
  • Fastest growing: India at 18.3% a year.
  • Hong Kong ranks 6th of 10 by size in APAC.

Market size projection

Hong Kong

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$0.4 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Bacteriophage Therapy Market market size by year, Hong Kong
YearMarket sizeChange that yearSince 2025
2024 (estimate) $0.1 Mn — —
2025 (base) $0.1 Mn +$0.0 Mn —
2026 (forecast) $0.2 Mn +$0.0 Mn +15.8%
2027 (forecast) $0.2 Mn +$0.0 Mn +34.1%
2028 (forecast) $0.2 Mn +$0.0 Mn +55.3%
2029 (forecast) $0.2 Mn +$0.0 Mn +79.8%
2030 (forecast) $0.3 Mn +$0.0 Mn +108.2%
2031 (forecast) $0.3 Mn +$0.0 Mn +141.1%
2032 (forecast) $0.4 Mn +$0.1 Mn +179.2%
2033 (forecast) $0.4 Mn +$0.1 Mn +223.3%
2034 (forecast) $0.5 Mn +$0.1 Mn +274.4%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $79.4 Mn
  2. North America $40.1 Mn
  3. US $30.2 Mn
  4. APAC $18.6 Mn
  5. Europe $14.9 Mn
  6. China $6.5 Mn
  7. Canada $6.2 Mn
  8. Japan $4.6 Mn
  9. Middle East $3.6 Mn
  10. Latin America $3.5 Mn
  11. Germany $2.9 Mn
  12. UK $2.2 Mn
  13. Brazil $2.1 Mn
  14. France $2.1 Mn
  15. Italy $1.7 Mn
  16. Ecuador $1.6 Mn
  17. India $1.5 Mn
  18. Saudi Arabia $1.4 Mn
  19. Spain $1.3 Mn
  20. Africa $1.2 Mn
  21. Mexico $1.2 Mn
  22. Australia $0.9 Mn
  23. New Zealand $0.8 Mn
  24. Russia $0.8 Mn
  25. South Africa $0.5 Mn
  26. UAE $0.4 Mn
  27. Egypt $0.1 Mn
  28. Hong Kong (this report) $0.1 Mn
  29. Malaysia $0.1 Mn
  30. Philippines $0.1 Mn
  31. Singapore $0.1 Mn
  32. Thailand $0.1 Mn
  33. Kenya $0.0 Mn

Report snapshot

Hong Kong Bacteriophage Therapy Market Analysis at a glance
Market size, 2025$0.1 Mn placeholder estimate
Forecast, 2034$0.5 Mn placeholder estimate
Growth (CAGR), 2025–203415.8% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsType, application and end user (see all)
Key playersArmata Pharmaceuticals, Locus Biosciences, Adaptive Phage Therapeutics, BiomX, Intralytix (see all)
Regulator in Hong KongDrug OfficeSource: Drug Office, Department of Health. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Hong Kong Bacteriophage Therapy Market Analysis Executive Summary

Bacteriophage therapy uses viruses that infect only bacteria to treat infections that antibiotics cannot clear.

Key segments of the bacteriophage Therapy market include type (Natural Phages, Engineered Phages and Phage Cocktails) and application (Chronic Wounds, Respiratory Infections and Urinary Infections).

Bar chart: Hong Kong Bacteriophage Therapy market size, 2024–2034, placeholder estimates. $0.1 Mn in 2024, $0.1 Mn in 2025 and $0.5 Mn in 2034, 15.8% CAGR.
Hong Kong Bacteriophage Therapy market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Hong Kong Bacteriophage Therapy Market Dynamics

Market Growth Drivers

Rising antimicrobial resistance, outbreaks of new and returning diseases, climate change spreading infections and strong global funding for prevention are driving the bacteriophage Therapy market.

Opportunity

New vaccines, rapid tests and public-private funding for neglected diseases give the bacteriophage Therapy market room to grow, especially in Asia, Africa and Latin America.

Market Restraints

Low prices in poorer markets, weak returns for new antibiotics, vaccine hesitancy and cold-chain problems hold back the bacteriophage Therapy market.

Competitive Landscape for Bacteriophage Therapy Market in Hong Kong

The bacteriophage Therapy market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Bacteriophage Therapy Market in Hong Kong

Bacteriophage Therapy in Hong Kong: rules and payment

Pharmaceutical products must be registered with the Pharmacy and Poisons Board before sale, through the Drug Office of the Department of Health.⁠[1] Public hospitals and clinics, run by the Hospital Authority, are heavily subsidised by the government.⁠[2]

[1] Drug Office, Department of Health. Checked 14 Nov 2026.

[2] Hospital Authority. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for bacteriophage Therapy. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Hong Kong.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Bacteriophage Therapy right now, from free public sources.

Latest research 957 papers since 2021 (worldwide)

  1. Bacteriophage associated liver injury in a person with cystic fibrosis and prior liver transplantation. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2026
  2. Prophylactic Post-lung Transplant Bacteriophage Therapy Against XDR Pseudomonas aeruginosa in Cystic Fibrosis: A Case Report. Infection, 2026
  3. Receptor-Targeted Sequential Phage Dosing against Pseudomonas aeruginosa PAO1: An In Vitro Proof-of-Concept Study. Pharmaceutical research, 2026
  4. Antibiotics and antibiotic resistance race: a chronicle of antibiotic discovery against Gram-negative bacteria during 2001-2020: way forward. Iranian journal of microbiology, 2026
  5. HydroGuard: a controlled release hydrogel-phage delivery system to combat catheter-associated urinary tract infections. Frontiers in systems biology, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Bacteriophage Therapy in context

Hong Kong compared

  • People aged 65 and over: 23.7% of people (2025). World: 10.4% of people (2025). 2nd highest of the 16 countries we cover in APAC.[1]

[1] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Bacteriophage Therapy market in Hong Kong?
Placeholder estimate: about $0.1 Mn in 2025, rising to about $0.5 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Bacteriophage Therapy market in Hong Kong growing?
Placeholder estimate: about 15.8% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Bacteriophage Therapy market report cover?
The report splits the market by type (Natural Phages, Engineered Phages, Phage Cocktails), application (Chronic Wounds, Respiratory Infections, Urinary Infections, Animal Health) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the Bacteriophage Therapy market?
Key players include Armata Pharmaceuticals, Locus Biosciences, Adaptive Phage Therapeutics, BiomX and Intralytix.
What is driving the Bacteriophage Therapy market?
Rising antimicrobial resistance, outbreaks of new and returning diseases, climate change spreading infections and strong global funding for prevention are driving the bacteriophage Therapy market.
Who regulates Bacteriophage Therapy in Hong Kong?
Pharmaceutical products must be registered with the Pharmacy and Poisons Board before sale, through the Drug Office of the Department of Health. Source: Drug Office, Department of Health. Checked 14 Nov 2026.
How is healthcare paid for in Hong Kong?
Public hospitals and clinics, run by the Hospital Authority, are heavily subsidised by the government. Source: Hospital Authority. Checked 14 Nov 2026.
How much research is published on Bacteriophage Therapy?
PubMed lists 957 papers on Bacteriophage Therapy added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Bacteriophage Therapy in Hong Kong? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Molecular Point-of-Care Tests: Lab Accuracy, Clinic SpeedTB killed 1.23 million people in 2024. WHO now recommends rapid molecular tests first, bringing lab-grade… Antimicrobial Resistance: Why Faster Testing MattersDrug-resistant infections already kill over a million people a year. Faster testing helps doctors pick the… Needleless Connectors: Small Device, Big Infection ImpactNeedleless connectors protect staff from needle injuries, but if not cleaned they can let germs into the…
Back to Catalogue
Keep exploring

Related Pharmaceuticals reports in Hong Kong

See all
Same topic, other categories

Related on antibiotics and infectious diseases

See the topic